European Biomedical Research Infrastructures and the Fight against COVID-19 Pandemic

Sovrem Tekhnologii Med. 2021;13(1):6-13. doi: 10.17691/stm2021.13.1.01. Epub 2021 Feb 28.

Abstract

The study aims to assess the role of EU biomedical research infrastructures in the fight against the COVID-19 pandemic and to analyze their response to the challenges associated with the spread of the new pathogen.

Materials and methods: We analyzed the materials of the Seventh Framework Program for Research and Technological Development (FP7, 2007-2013) of the EU and the Eighth Framework Program "Horizon 2020" (FP8, 2014-2020), official reports of the European Strategic Forum on Research Infrastructures, expert reports, as well as documents of the European Commission, the COVID-19 Data Portal, and other relevant sources of information.

Results: The analysis revealed that the mechanisms created within the united European research community provided for a flexible response to the emerging threat of COVID-19 as soon as January-May 2020. In particular, information channels were established to timely analyze the research results and coordinate the efforts in the fight against COVID-19. The biomedical infrastructures created in the EU and proved successful earlier have now been mobilized to search for ways of preventing and treating COVID-19. These mechanisms facilitated communication and data exchange between various research institutions and thus laid the ground for new achievements in this area.

Conclusion: The decisions taken to combat the COVID-19 pandemic have convincingly illustrated that the EU research infrastructures, integrated into a united ecosystem, are highly adaptable and flexible, which allows to realign priorities in a short time and to create instruments that enable scientists to respond to new challenges.

Keywords: COVID-19; ESFRI; EU; EU biomedical research infrastructures; innovations; research.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Biological Specimen Banks
  • Biomedical Research / organization & administration*
  • COVID-19 Vaccines / pharmacology
  • COVID-19*
  • Clinical Trials as Topic
  • European Union
  • Health Information Exchange
  • Humans
  • Information Storage and Retrieval
  • International Cooperation
  • Translational Research, Biomedical / organization & administration

Substances

  • Antiviral Agents
  • COVID-19 Vaccines

Grants and funding

Research funding. State assignment No.AAA-A17-117080110023-6 MSU.